Newsroom
Sorted by: Latest
-
NATIXIS UK Regulatory Announcement: Form 8.3 - Amendment
LONDON--(BUSINESS WIRE)-- FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) AMENDED – This disclosure replaces the one published on February 12, 2026 05:50 AM Eastern Standard Time – Ticker has been updated for linking purposes. 1. KEY INFORMATION (a) Full name of discloser: NATIXIS SA (b) Owner or controller of interests and short positions disclosed, if different...
-
Hello, Cincinnati: CAVA’s Expansion Into the Midwest Continues
WASHINGTON--(BUSINESS WIRE)--CAVA (NYSE: CAVA), the category-defining Mediterranean fast-casual restaurant brand, opened its doors today at 3356 Madison Road in Cincinnati, Ohio. CAVA Oakley Station is a 3,200-square-foot location with a bright dining room, convenient digital order pick-up, and delivery options designed to meet guests where they are depending on the day - bringing bold, craveable Mediterranean flavors that will leave Cincinnati guests feeling energized, satisfied, and well nour...
-
NATIXIS UK Regulatory Announcement: Form 8.3 - Amendment
LONDON--(BUSINESS WIRE)-- FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) AMENDED – This disclosure replaces the one published on February 13, 2026 05:33 AM Eastern Standard Time – Ticker has been updated for linking purposes. 1. KEY INFORMATION (a) Full name of discloser: NATIXIS SA (b) Owner or controller of interests and short positions disclosed, if different...
-
New Guardant Health/Harris Poll Survey Shows 92% of All Eligible Americans Believe Colorectal Cancer Blood Tests Should be Accessible and Covered Similar to Medicare
PALO ALTO, Calif.--(BUSINESS WIRE)--Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced the results of a new national survey conducted on its behalf by The Harris Poll with findings demonstrating that more than 9 out of 10 Americans ages 45 and over believe in ensuring broader coverage for blood-based colorectal cancer (CRC) screening, including new innovations like Shield™ by Guardant, a methylation partitioning cell-free DNA (mp-cfDNA) test and the first...
-
P3 Health Partners Schedules Fourth Quarter and Full Year 2025 Earnings Release and Conference Call
HENDERSON, Nev.--(BUSINESS WIRE)--P3 Health Partners Inc. (“P3” or the “Company”) (NASDAQ: PIII), a patient-centered and physician-led population health management company, today announced that the Company plans to release its financial results for fourth quarter and full year 2025 on Thursday, March 26, 2026. In connection with the release, management will host a conference call to discuss the financial results at 1:30pm PT/ 4:30pm ET the same day. Title & Webcast P3 Health Fourth Quarter...
-
Savara Reports Fourth Quarter and Year End 2025 Financial Results and Provides Business Update
LANGHORNE, Pa.--(BUSINESS WIRE)--Savara Inc. (Nasdaq: SVRA) (the Company), a clinical stage biopharmaceutical company focused on rare respiratory diseases, reported financial results for the fourth quarter and full year ending December 31, 2025 and provided a business update. “Over the last year, we significantly advanced the MOLBREEVI development program,” said Matt Pauls, Chair and Chief Executive Officer, Savara. “With the filing of the BLA, an assigned PDUFA date of August 22nd, and submiss...
-
Alto Neuroscience Announces Participation at the Stifel 2026 Virtual CNS Forum
MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--Alto Neuroscience, Inc. (“Alto”) (NYSE: ANRO) a clinical-stage biopharmaceutical company focused on the development of novel precision medicines for neuropsychiatric disorders, today announced that members of the Company’s management team will participate in a virtual fireside chat at the Stifel 2026 Virtual CNS Forum on March 17, 2026 at 12:00pm ET. The presentation will be accessible via a live webcast on the Events and Presentations page in the Investo...
-
Standard Nuclear Appoints Kevin Harrill as Chief Financial Officer
OAK RIDGE, Tenn.--(BUSINESS WIRE)--Standard Nuclear, a reactor-agnostic producer of TRISO nuclear fuel, today announced the appointment of Kevin Harrill, CPA, as Chief Financial Officer, effective March 9, 2026. Harrill joins the company as Standard Nuclear scales production capacity to meet growing demand for advanced nuclear fuel from commercial and government customers. Harrill most recently served as Senior Vice President and Chief Financial Officer of Centrus Energy Corp., where he was pre...
-
Lumentum Thought Leaders to Present at OFC 2026
SAN JOSE, Calif.--(BUSINESS WIRE)--Lumentum Holdings Inc. ("Lumentum") today announced its speaker line-up at the 2026 Optical Fiber Communication Conference and Exposition (OFC) in Los Angeles. Company executives and technical experts will share their perspectives on the optical communication market, including challenges and opportunities, and the technology shaping the future of AI data centers and optical networks. The event will be held from March 15–19 at the Los Angeles Convention Center....
-
Liberty Live Holdings, Inc. Enters into Exchange Agreements with Certain Holders of its 2.375% Exchangeable Senior Debentures due 2053
ENGLEWOOD, Colo.--(BUSINESS WIRE)--Liberty Live Holdings, Inc. Enters into Exchange Agreements with Certain Holders of its 2.375% Exchangeable Senior Debentures due 2053...